FTC accuses Ovation of price gouging
Pharma Compliance Alert, December 24, 2008
The Federal Trade Commission (FTC) filed suit in U.S. District Court in Minnesota against Ovation Pharmaceuticals, alleging the company created a monopoly and then forced hospitals to pay drastically increased prices.
The FTC claims the company purchased the rights to two pharmaceuticals used to treat a potentially fatal congenital heart defect in premature infants, then raised the price 1,300%.
The FTC wants Ovation to divest one of the two drugs and forfeit what it calls “unlawfully obtained profits.” The Minnesota attorney general also filed suit against the company.
In a statement, the company said it strongly disputes the FTC’s allegations, adding that the two products are not interchangeable in most premature infants.
Comments
0 comments on “FTC accuses Ovation of price gouging ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched
